Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Sanderson Farms, Misonix, and Steadfast Apartment REIT on behalf of Stockholders and Encourages Investors to Contact the Firm
01. Oktober 2021 16:51 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Sanderson Farms, Inc....
Moore Kuehn Encourages MSON, LMRK, SAFM, and SVBI Investors to Contact Law Firm
23. September 2021 12:01 ET
|
Moore Kuehn
NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
02. September 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
MISONIX ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MSON and Encourages Investors to Contact the Firm
30. Juli 2021 14:59 ET
|
Bragar Eagel & Squire
NEW YORK, July 30, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
29. Juli 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 29, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Appoints Patrick J. Beyer to Board of Directors
14. Mai 2021 08:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 14, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Participate in Upcoming May and June Virtual Investor Conferences
10. Mai 2021 13:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Reports Fiscal 2021 Third Quarter Financial Results
06. Mai 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6
20. April 2021 08:15 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Receives Health Canada Approval for neXus
04. März 2021 09:25 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...